AstraZeneca Plc’s diabetes drug Onglyza may be associated with an increased rate of death, according to a preliminary review of…
Read MoreAstraZeneca Plc’s diabetes drug Onglyza may be associated with an increased rate of death, according to a preliminary review of…
Read MoreIn recent years, vitamin D has gained a reputation for being a miracle nutrient of sorts— boasting benefits from improving…
Read MoreA new drug for type 2 diabetes could be activated exactly when it’s needed by shining a blue light on…
Read More